An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging
- Conditions
- Skin Aging
- Registration Number
- NCT00492479
- Lead Sponsor
- Innovative Medical
- Brief Summary
The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- Not specified
- Female patients 35-55 years of age with at least moderate signs of facial aging
- Written informed consent
- Likely to complete all study visits and follow study protocol
-
Any dermatological or medical condition which would make patient participation unsafe or interfere with study outcomes or measurements
-
Known hypersensitivity to any study product or their components
-
Recent (within 4 weeks of baseline) surgical treatment to face (including IPL and other laser procedures)
-
Prior use of anti-aging treatments for 30 days prior to study entry (physician dispensed or prescribed treatments)
-
Planned facial procedures during the study (microdermabrasion, facials, etc)
o Botox and fillers cannot be used during the trial or for 3 months prior to study entry
-
Recent (within 60 days) or concurrent participation in another clinical trial
-
Concomitant topical or systemic therapy that my interfere with study measurements or outcomes
-
Use of any other topical photoaging/antiaging therapies during the study, other than the prescribed study regimens
-
Patients who are habitual tanners (outdoors or with tanning beds) who plan on tanning during the study
-
Wearing of cosmetics during study visits
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Steve Yoelin MD practice
🇺🇸Santa Ana, California, United States